Bill Gilet’s Post

🌐 The evolution of Next-Gen Global Business Services (GBS) is reshaping the pharmaceutical and life sciences industry. From enhanced efficiency and collaboration in R&D to commercial gains and reliable supply chain management, this model empowers businesses to thrive. Discover how Next-Gen GBS can help drive innovation, cost savings, and better outcomes across the pharma and life sciences value chain.

🌐 The evolution of Next-Gen Global Business Services (GBS) is reshaping the pharmaceutical and life sciences industry. From enhanced efficiency and collaboration in R&D to commercial gains and reliable supply chain management, this model empowers businesses to thrive. Discover how Next-Gen GBS can help drive innovation, cost savings, and better outcomes across the pharma and life sciences value chain.

🌐 The evolution of Next-Gen Global Business Services (GBS) is reshaping the pharmaceutical and life sciences industry. From enhanced efficiency and collaboration in R&D to commercial gains and reliable supply chain management, this model empowers businesses to thrive. Discover how Next-Gen GBS can help drive innovation, cost savings, and better outcomes across the pharma and life sciences value chain.

🌐 The evolution of Next-Gen Global Business Services (GBS) is reshaping the pharmaceutical and life sciences industry. From enhanced efficiency and collaboration in R&D to commercial gains and reliable supply chain management, this model empowers businesses to thrive. Discover how Next-Gen GBS can help drive innovation, cost savings, and better outcomes across the pharma and life sciences value chain.

Did You Know? Emerging pharma manufacturers face the same commercialization hurdles as big pharma but often with fewer resources. Our 0 to 60 Guidebook offers a comprehensive roadmap to help emerging pharma companies streamline every step of the commercialization process. So, what's inside? • How we help emerging manufacturers do more with less • The full range of Two Labs’ integrated solutions • Two Labs’ expertise and results after 20+ years of serving the biopharma industry Download the guidebook now and discover how to accelerate your commercialization journey: https://bit.ly/47KErLp

🌟 Science Exchange is proud to be at the forefront of transforming R&D processes in the Pharmaceutical & Life Sciences (PLS) industry.  🧪💼 In this article, we're excited to see the spotlight on transitioning from traditional operations to tech-enabled, efficient processes. It aligns perfectly with our core mission and the impact we're making on the #PLS industry. 🚀 We harness technology and strategic cost management to redefine how R&D organizations work with suppliers. Leading #pharmaceutical companies, #biotechs, and #academics have embraced our #supplierorchestration platform, enabling them to streamline and optimize their research and development processes. The result? Faster, more accurate, and highly efficient operations. 💡 Our platform offers streamlined #projectmanagement and #procurement processes, reducing the time and resources spent on administrative tasks. This allows researchers to dedicate more effort to their core scientific work, driving #scientificdiscovery at an accelerated pace. We’re inspired to see thought leaders like PwC recognizing the immense potential within R&D for executives to cut costs without compromising their mission or critical capabilities. ✨ #NextGenGBS #ResearchandDevelopment #PharmaIndustry #LifeSciences #Technology

📈 Many pharmaceutical and life science companies are now taking a fresh look at their operating models. Next-Gen Global Business Services (GBS) can play a bigger role in how these companies reinvent work across the value chain. Discover how this innovative approach can help drive advanced business outcomes at lower costs and faster speeds. Very proud of the work our team is doing to support clients on this journey. #PharmaIndustry #NextGenGBS #Innovation

This is your final opportunity to sign up for the Endpoints Manufacturing Day 2024, taking place tomorrow! 📅 Date: Tuesday, August 6, 2024 🕚 Time: 11 AM - 1:30 PM Be part of a gathering with top industry experts, including our very own CEO William Humphries, as they delve into strategies for dealing with the intricate demands of global supply, regulatory hurdles, and the increasing expenses in the field of pharmaceutical manufacturing. Speakers Include: 🔹 Bill Humphries, CEO at Alcami 🔹 John Chiminski, previous CEO and Chairman at Catalent 🔹 Christian Jones, Chief Commercial Officer at Nanoform 🔹 Hayley Crowe, Executive Vice President, Pharma at Ecolab With moderation by: 🔹 Kurt Nielsen, Ph.D., ex-CEO at Pii and former CTO at Catalent Don't miss out on this crucial conversation aimed at defining the future landscape of pharmaceutical manufacturing. We're excited to welcome you! Secure Your Spot! ➡️ https://gag.gl/GTFfim #ManufacturingDay2024 #PharmaManufacturing #CDMO #Innovation #SupplyChain

Tomorrow, Friday, June 28th - Don't miss out on the opportunity to learn how Pfizer is using Digital Twin technology in modern facility management. Explore the transformative power of Digital Twin technology in this insightful webinar - register here: https://lnkd.in/egZrGHjp Through real-world examples and expert insights, Austin Brown from Pfizer and Nick Armstrong from CAI will show you how virtual replicas of physical facilities can revolutionize operations, maintenance, and strategic planning across various industries. If you can't make the date, no worries - by registering you will get a link to the recorded webinar so you can watch it on-demand. #pharmaceuticalmanufacturing #pharmaceuticaloperations #facilitiesmanagement #digitaltwin Ideal event for IT, Supply Chain, Manufacturing, Quality, Digitization SMEs at Merck, Novartis, Amgen, Eli Lilly and Company, Thermo Fisher Scientific, Catalent Pharma Solutions, Bayer, Boehringer Ingelheim, Corden Pharma - A Full-Service CDMO, Scorpius BioManufacturing, Inc., Teva Pharmaceuticals, Regeneron, ISPE, PDA - Parenteral Drug Association, ISPE Boston Area Chapter, ISPE Greater Los Angeles Area Chapter, ISPE Midwest Chapter, ISPE-CaSA, ISPE CaSA Women in Pharma, PDA Italy Chapter, ISPE United Kingdom Affiliate Ltd, ISPE United Kingdom Pharma 4.0 COP, FDA, PCI Pharma Services, Berkshire Sterile Manufacturing, Grand River Aseptic Manufacturing

In today's competitive and rapidly-evolving pharmaceutical biotech manufacturing landscape, efficiency, sustainability, and profitability are essential elements in facility design and operation. 🔬 Recognizing this, Brandon Hiatt shared his insights on overcoming challenges like supply chain delays, labor shortages, and evolving regulations to help facility managers and business leaders alike create spaces that support cutting-edge research and development while also driving long-term value. Read the full article in Lab Design News. ⬇ https://hubs.li/Q02Ygx2l0